Chemistry:Vepugratinib

From HandWiki

Vepugratinib is an investigational new drug that is being evaluated by Loxo Oncology for the treatment of genitourinary cancer.[1] It is a fibroblast growth factor receptor 3 antagonist.[1][2]

References

  1. ↑ 1.0 1.1 "Vepugratinib". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800065832. 
  2. ↑ "Next-generation isoform-selective fibroblast growth factor receptor inhibitors". Trends in Pharmacological Sciences 46 (11): 1091–1104. November 2025. doi:10.1016/j.tips.2025.09.004. PMID 41125482. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Vepugratinib&oldid=4583698"